Excel spreadsheet containing, in separate sheets, the underlying numerical data and statistical analysis for Figs 1B, 1C, 1E, 1F, 1G, 2A, 2B, 3, 4B, 4C, 4D, 4E, 4F, 4G, 5A, 5B, 5C,... by Xi-Meng Sun (17721428)

Hypothalamic AAV-TrkB.FL overexpression decreases body weight gain in HFD BTBR mice. by Jacqueline M. Anderson (14769007)

Chondrocyte proliferation and apoptosis analysis. (A) Rabbit chondrocyte proliferation was detected by the MTT method <i>in vitro</i>. by Ronglan Zhao (658986)

TLR4 receptor inhibition decreased ranibizumab and aflibercept mediated CCL2, CCL5, and CX3CL1 mRNA and protein levels in HCAECs. by Clare Arnott (2557705)

Hypothesis that explains and predicts expansion of ages of KD due to decreased IgG levels. by Hiromi Yamaguchi (2396248)

Subjects:

Effects of serum 25-hydroxyvitaminD level on decreased bone mineral density at femoral neck and total hip in Chinese type 2 diabetes by Liting Guo (4634071)

“…</p><p>③ Compared with hemoglobin A1c (HbA1c) ≤8% group, 25OHD and BMDs at the femoral neck and total hip in HbA1c>8% group decreased [(40±15 vs. 32±13 nmol/l), (0.89±0.13 vs. 0.83±0.13 g/cm²), (0.95±0.13 vs. 0.83±0.16 g/cm²) (All P<0.05)] and the parathyroid hormone level increased (7.2±4.0 vs. 10.0±8.8 pmol/L) (P<0.05).…”

SARS-CoV‑2 Delta Variant Decreases Nanobody Binding and ACE2 Blocking Effectivity by Mert Golcuk (10789806)

SARS-CoV‑2 Delta Variant Decreases Nanobody Binding and ACE2 Blocking Effectivity by Mert Golcuk (10789806)

Male mice born from DIO dams display decreases in monoacylglycerol lipase (MGL) expression in jejunum mucosa. by Pedro A. Perez (5807615)

Changes in neural activity were decreased in animals pre-exposed to 5-HT and <i>mod-1</i> mutants when the worms switched their locomotive direction. by Haruka Mori (8082215)

“…<p>(A–F) the neural activity of the RID changes during the transition periods from backward to forward locomotion (A–C) and from forward to backward locomotion (D–F) in the mock (A: p = 1.5 × 10⁻⁵; D: p = 5.5 × 10⁻¹³), 5-HT exposed (B: p = 0.092; E: p = 0.79), and <i>mod-1</i> mutant (C: p = 0.081; F: p = 0.93) groups. …”

Multivariable longitudinal analysis of short, mid and long-term prognostic factors for decreased health status as measured with the EQ-5D-3L. by Nena Kruithof (8741346)

Glutamate, succinate, and palmitoyl-L-carnitine-supported oxygen consumption decreased mildly with HFD, but recovered over time. by Pamela A. Kakimoto (6294206)

Clinical factors affecting renal response to dulaglutide. by Sungmin Kim (628527)

Subjects:

eGFR values and mean eGFR change after the use of dulaglutide. by Sungmin Kim (628527)

Subjects:

Lack of SOD activity in strain CAM.02 decreases intracellular H₂O₂ levels. by Tiago Beites (195644)

AQP4 abundance. by Sophie Constantin Lütken (689916)

Subjects:

(Pro)renin receptor abundance. by Sophie Constantin Lütken (689916)

Subjects:

AQP1 abundance. by Sophie Constantin Lütken (689916)

Subjects:

Type 1_A angiotensin II receptor abundance. by Sophie Constantin Lütken (689916)

Subjects:

Gsα subunit abundance. by Sophie Constantin Lütken (689916)

Subjects: